Global Fecal Immunochemical Diagnostic Tests Market Size To Exceed USD 2.51 Billion By 2033
According to a research report published by Spherical Insights & Consulting, The Global Fecal Immunochemical Diagnostic Tests Market Size is Expected to Grow from USD 1.38 Billion in 2023 to USD 2.51 Billion by 2033, at a CAGR of 6.16% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on The Global Fecal Immunochemical Diagnostic Tests Market Size, Share, and COVID-19 Impact Analysis, By Product (Kits & Reagents, Analyzers, and Others), By End-User (Hospitals & Diagnostics Laboratories, Specialty Clinics, Home Care Settings, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The global fecal immunochemical diagnostic tests market means the worldwide market for diagnostic tests that identify occult blood in feces specimens using immunochemical techniques. These tests find their main application as a screening test for colorectal cancer (CRC) and in identifying gastrointestinal bleeding. Furthermore, the world fecal immunochemical diagnostic test market is fostered by enhancing awareness of colorectal cancer screening, rising rates of gastrointestinal ailments, movement away from invasive types of testing, growing elderly populations, and facilitation of governmental screening programs. Advancements enhancing test sensitivity and the rise of home testing kit usage also account for considerable development and availability within the market. However, Key restraining factors in the global fecal immunochemical diagnostic tests market include limited awareness in low-income regions, inadequate screening infrastructure, and cultural stigma around stool-based testing. Additionally, false-negative results, lack of standardization in test interpretation, and regulatory hurdles for new product approvals hinder broader adoption, particularly in emerging markets with limited healthcare access and diagnostics penetration.
The kits & reagents segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the product, the global fecal immunochemical diagnostic tests market is divided into kits & reagents, analyzers, and others. Among these, the kits & reagents segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to their frequent use in routine screening, ease of availability, and recurring demand in diagnostic labs. Increasing colorectal cancer screening programs, coupled with advancements in reagent sensitivity and automation compatibility, continue to drive this segment's significant growth through the forecast period.
The hospitals & diagnostics laboratories segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the end-user, the global fecal immunochemical diagnostic tests market is segmented into hospitals & diagnostics laboratories, specialty clinics, home care settings, and research institutes. Among these, the hospitals & diagnostics laboratories segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is ascribed to their widespread infrastructure, access to advanced diagnostic equipment, and higher patient footfall. Growing emphasis on early colorectal cancer detection, government-led screening initiatives, and improved reimbursement policies are expected to further boost this segment’s robust growth in the coming years.
North America is projected to hold the largest share of the global fecal immunochemical diagnostic tests market over the forecast period.
North America is projected to hold the largest share of the global fecal immunochemical diagnostic tests market over the forecast period. The regional growth is ascribed to high colorectal cancer prevalence, well-established healthcare infrastructure, and widespread adoption of preventive screening programs. Favorable reimbursement policies, government-funded awareness initiatives, and the presence of leading diagnostic companies further support the region's dominance throughout the forecast period, driving sustained market growth.
Asia Pacific is expected to grow at the fastest CAGR growth of the global fecal immunochemical diagnostic tests market during the forecast period. The regional growth is attributed to the increasing healthcare investments, rising awareness of colorectal cancer, and growing adoption of non-invasive diagnostic methods. Expanding aging population, improving access to healthcare services, and supportive government screening initiatives further drive demand, particularly in rapidly developing countries like China, India, and Japan.
Company Profiling
Major vendors in the global fecal immunochemical diagnostic tests market are Quest Diagnostics Incorporated, Sentinel CH. SpA, FUJIFILM Corporation, Quidel Corporation, Danaher (Beckman Coulter, Inc.), Eiken Chemical Co., Ltd., Freenome Holdings, Inc., Immunostics, Inc., BTNX, Inc., Biohit Oyj., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In November 2022, based on the in Vitro Diagnostic Regulation, Eiken Chemical Co., Ltd. introduced the "OC-SENSOR Ceres," a fully automated fecal immunochemical test/fecal calprotectin analyzer that meets the CE Mark requirements.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global fecal immunochemical diagnostic tests market based on the below-mentioned segments:
Global Fecal Immunochemical Diagnostic Tests Market, By Product
- Kits & Reagents
- Analyzers
- Others
Global Fecal Immunochemical Diagnostic Tests Market, By End-User
- Hospitals & Diagnostics Laboratories
- Specialty Clinics
- Home Care Settings
- Research Institutes
Global Fecal Immunochemical Diagnostic Tests Market, By Regional
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa